Elsevier

Atherosclerosis

Volume 91, Issues 1–2, November 1991, Pages 107-116
Atherosclerosis

Research paper
Role of inflammatory responses in initiation of atherosclerosis: effects of anti-inflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery

https://doi.org/10.1016/0021-9150(91)90192-6Get rights and content

Abstract

Immediately after a cuff-sheathing of rabbit carotid artery, a large number of leukocytes adhered to injured endothelium then infiltrated into the media. These inflammatory responses were followed by an atherosclerosic change, intimal thickening, of the artery. A simultaneous injection of dexamethasone (10 mg/kg i.m.) inhibited the leukocyte accumulation by 74% when evaluated 18 h thereafter. Similarly, 39% inhibition was obtained with the same dose of FR110302, a potent 5-lipoxygenase inhibitor. On the other hand, the same dose of indomethacin, a cyclooxygenase inhibitor, had little effect on the leukocyte accumulation. The intimal thickening which was evaluated 3 weeks after the cuff-treatment was attenuated by a daily dose (10 mg/kg i.m.) of dexamethasone or FR110302 but not by one of indomethacin. The inhibition by the two former drugs were 91 and 58%, respectively. In vitro, the three drugs in concentrations up to 10 AM hardly affected endothelial adhesion of PMN which was induced by LPS or IL-1. Though 10 μM of FR110302 and indomethacin significantly decreased PMN chemotaxis induced by LTB4, the decreases were less than that at 10 μM dexamethasone. These results confirm a possible linkage between inflammation and atherosclerosis, and suggest that 5-lipoxygenase products contribute to the initiation and development of atherosclerosis.

References (20)

There are more references available in the full text version of this article.

Cited by (34)

  • Glucocorticoids are active players and therapeutic targets in atherosclerotic cardiovascular disease

    2020, Molecular and Cellular Endocrinology
    Citation Excerpt :

    The decrease in atherosclerosis burden in dexamethasone-treated rabbits in the study by Asai et al. (1993) coincided with a reduction in the lesional macrophage and lymphocyte content. Notably, findings from Hagihara et al. (1991) have shown that dexamethasone treatment markedly lowers the adhesion of leukocytes to the aortic endothelium, which also explains the dexamethasone-induced protection to cuff-induced intimal thickening observed in Japanese white rabbits. Anti-inflammatory glucocorticoid administration to rabbits, i.e. oral prednisone treatment, similarly reduces the restenosis extent in response to stent implantation into atherosclerosis-containing iliac arteries (Ribichini et al., 2007).

  • Engineered nanoparticles for the detection, treatment and prevention of atherosclerosis: how close are we?

    2017, Drug Discovery Today
    Citation Excerpt :

    Statins have been touted as the gold standard of blood-cholesterol-reducing drugs, lowering LDL levels and atherosclerotic risk [17]. Concurrently, different corticosteroids such as dexamethasone [18] and prednisolone [19] have been widely explored for reducing inflammation. At the later stages of atherosclerosis, anticoagulant or thrombolytic therapies and surgical intervention such as angioplasty, bypass grafting and stenting are more prevalent.

  • Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line

    2003, Journal of Lipid Research
    Citation Excerpt :

    Atherosclerosis-prone mice (apoE−/−) that lack CD36 expression (CD36−/−) have markedly reduced atherosclerotic lesion size (17). Dexamethasone has been shown to decrease atherosclerotic lesion size in several animal models (46–49). However, the role of aP2 and CD36 in the response of atherosclerotic lesion inhibition by dexamethasone remains to be tested.

  • Pathogenetic heterogeneity of in-stent lesion formation in human peripheral arterial disease

    2002, Journal of Vascular Surgery
    Citation Excerpt :

    Although we are now unsure which factor(s) promoted the accumulation of proteoglycans in the inner intima, there is a possibility that an unknown factor is secreted at the luminal surface. An experimental study with an arterial cuff model showed that a cuff, placed around the arterial adventitia, induced adhesion of leukocytes to the luminal surface as an inflammatory response to the foreign body.25,26 Because a stent is also a foreign body, we think that leukocytes in the blood vessel possibly adhere to the surface of the intimal lesion, even though the stent is completely covered by neointima.

View all citing articles on Scopus
View full text